10:26 AM · 4 August 2025

Economic/corporate calendar: Swiss inflation/US orders; Berkshire Hathaway and Palantir Technologies earnings (04.08.2025)

USD/CHF
Forex
-
-
Berkshire
Stocks
BRKB.US, Berkshire Hathaway Inc - class B
-
-
Palantir
Stocks
PLTR.US, Palantir Technologies Inc - class A
-
-
  • Futures Gain Before the Opening of the European Cash Session
  • Investors' Attention Will Turn to Swiss CPI Data and US Durable Goods Orders

The start of Monday's trading session promises to be relatively quiet. Futures contracts in Europe and the US are gaining value after significant declines on Friday. The EU50 contract is currently up 0.45%, and the US500 is up 0.38%. Today's macro calendar will focus on Swiss CPI data and US durable goods orders.

Investors will also be paying attention to numerous quarterly earnings releases. Warren Buffett's Berkshire Hathaway Inc. reported its results this Saturday, and today's earnings will include MercadoLibre Inc., Palantir Technologies Inc., and Hims & Hers Health Inc.

Detailed macro and company calendar (source: xStation, author's own analysis):

 

 

 

14 October 2025, 8:50 PM

EURUSD higher after Powell's speech! 💶📈

14 October 2025, 8:19 PM

Salesforce announces partnerships with OpenAI and Anthropic🚨

14 October 2025, 7:25 PM

Intel down 5% 📉

14 October 2025, 6:56 PM

JPMorgan, Goldman Sachs, and Citigroup: Sector Overview and Challenges

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.

Join over 1 700 000 investors from around the world

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer, especially CFDs, can be highly risky. Please consider if you understand the risks and can afford the loss of capital. XTB is regulated by the SCA

The financial instruments we offer are risky. XTB is regulated by the DFSA.